Side-by-side comparison of AI visibility scores, market position, and capabilities
AI cloud computing platform for life sciences microscopy images and NGS sequencing data management; $2.1M a16z pre-seed backed YC W21 at $750K ARR serving biotech and academic research labs.
Biodock is a San Francisco-based AI cloud computing platform for life sciences research — providing data management, analysis, and collaboration infrastructure specifically designed for biological research data including microscopy images, next-generation sequencing (NGS) outputs, and other large-scale biological datasets that overwhelm general-purpose cloud storage and analytics tools. Founded in 2020 and backed by Andreessen Horowitz in a pre-seed round with $2.1-2.33 million raised, plus notable angel investors from Tiger Global and Flatiron Health, Biodock (YC W21) reached $750,000 in annual revenue as of June 2025.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.